1. Background
2. Objectives
3. Methods
3.1. Study Design and Setting
3.2. Sample Size and Sampling
3.3. Inclusion and Exclusion Criteria
3.4. Data Collection Tool
3.5. Data Analysis
3.6. Ethical Considerations
3.7. Data Extraction and Inter-Rater Reliability
3.8. Root Cause Analysis Approach
4. Results
| Data Item | Operational Definition | Documented (n) | Percentage (%) |
|---|---|---|---|
| National ID | Clear, legible, and correct | 610 | 98.2 |
| Age | Recorded in years | 610 | 98.2 |
| Gender | Male or female clearly indicated | 620 | 99.8 |
| History of HTN | Present/absent clearly stated | 435 | 70.0 |
| History of DM | Present/absent clearly stated | 410 | 66.0 |
| History of coagulopathy | Present/absent clearly stated | 342 | 55.1 |
| History of prior CVA | Present/absent clearly stated | 370 | 59.6 |
| Drug allergy | Specific allergen stated or "none" recorded | 602 | 96.9 |
| Data Item | Operational Definition | Documented (n) | Percentage (%) |
|---|---|---|---|
| Preoperative | |||
| Primary diagnosis on surgery request | Specific diagnosis (eg, disc herniation or tumor) | 571 | 91.9 |
| Informed consent form | Signed by patient or legal guardian | 569 | 91.6 |
| CBC results | Hb, Hct, WBC, and platelet values recorded | 590 | 95.0 |
| Pre-anesthesia evaluation | Complete form signed by anesthesiologist | 482 | 77.6 |
| Intraoperative | |||
| Name of surgical procedure | Exact procedure name | 621 | 100 |
| Incision time | Hour and minute recorded | 383 | 61.7 |
| Closure time | Hour and minute recorded | 379 | 61.0 |
| Prophylactic antibiotic | Drug name, dose, and administration time all recorded | 307 | 49.4 |
| Intraoperative complication | Any complication explicitly stated, or "none" clearly documented | 98 | 15.8 |
| Data Item | Operational Definition | Documented (n) | Percentage (%) |
|---|---|---|---|
| Postoperative (ICU Admission) | |||
| GCS on ICU admission | First GCS recorded after OR transfer | 507 | 81.6 |
| Systolic BP on ICU admission | Numeric value in mm Hg | 532 | 85.7 |
| Pupil examination | Size, equality, and reaction to light all documented | 216 | 34.8 |
| IV antibiotic order | Drug name, dose, and time clearly ordered | 492 | 79.2 |
| Antiseizure medication order | Drug name, dose, and frequency | 419 | 67.5 |
| Pain/agitation protocol | Specific drug and dose ordered | 326 | 52.5 |
| Inter-Ward Transfer (ICU-to-Ward) | |||
| Last GCS before transfer | GCS recorded within 4 hours before transfer | 388 | 62.5 |
| Neurological status | Motor power and any new deficits documented | 233 | 37.5 |
| Active medication list | All medications to be continued on the ward listed | 123 | 19.8 |
| Data Item | Operational Definition | Documented (n) | Percentage (%) |
|---|---|---|---|
| Discharge summary | Complete clinical course and procedure summary | 538 | 86.6 |
| GCS at discharge | Last GCS before discharge recorded | 491 | 79.1 |
| Residual neurological deficits | Specific deficits or "none" | 405 | 65.2 |
| Discharge medications | Name, dose, duration, and quantity all specified | 452 | 72.8 |
| Follow-up visit date | Specific date for outpatient follow-up | 439 | 70.7 |
| Final pathology report | Histopathology report attached or summarized | 148 | 23.8 |
| Documentation Item | Elective (n = 497) | Emergency (n = 124) | P-Value |
|---|---|---|---|
| Pupil examination on ICU admission | 32.1 | 45.2 | 0.008 |
| GCS at transfer | 60.2 | 71.8 | 0.02 |
| Active medication list at transfer | 19.5 | 21.0 | 0.72 |
| Pathology report at discharge | 23.5 | 24.2 | 0.85 |
